Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
Surface indicators and our internal signals diverge — the score reflects the combined read.
Gilead generates most of its ~$29B revenue from HIV treatments (Biktarvy dominates), with growing oncology and liver disease franchises. Beta ~0.3, pays ~2.3% dividend. Very low vol for a biotech — behaves more like big pharma. Reliable premium decay for put sellers in stable markets.
Biotechnology — Antiviral & Oncology
Market Cap
$171.3B
P/E Ratio
—
Dividend
2.4%
Beta
0.34
52-Week RangeCurrent: $138.14
$108.46$157.29
Earnings
2026-10-29
76 days away
GILD — lower-band read with the weakness spread across dimensions rather than concentrated in one. The composite picture, not any single indicator, is the limiting factor.
GILD ranks #23 of 66 Healthcare tickers by put-selling score (619 total screened)
Position Size & Yield Calculator
Live model for GILD — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0—
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
⚠️ Single-name concentration. Consider diversifying across multiple tickers — or use a Bull Put Spread to commit less collateral per trade.
Calculator assumptions
Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.
This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
The GILD X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.